Jenna Beth Hall, OTR/L, DOT | |
1562 Monterey Valley Pkwy, Severance, CO 80550-3278 | |
(970) 581-3030 | |
Not Available |
Full Name | Jenna Beth Hall |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 1562 Monterey Valley Pkwy, Severance, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285210328 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | OT.0005516 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jenna Beth Hall, OTR/L, DOT 1562 Monterey Valley Pkwy, Severance, CO 80550-3278 Ph: (970) 581-3030 | Jenna Beth Hall, OTR/L, DOT 1562 Monterey Valley Pkwy, Severance, CO 80550-3278 Ph: (970) 581-3030 |
News Archive
You're about to leave work at the end of the day when your cell phone rings: it's your spouse, asking that you pick up a gallon of milk on the way home. Before you head out the door, though, your spouse calls again and asks you to stop by the hardware store too. Based on your knowledge of the area and rush-hour traffic, you decide to get the milk first and the toilet plunger second. But whoops! The phone rings again. This time, it's your boss, asking you to work late. That means another change of plans.
How we think and fall in love are controlled by lightning-fast electrochemical signals across synapses, the dynamic spaces between nerve cells. Until now, nobody knew that cancer cells can repurpose tools of neuronal communication to fuel aggressive tumor growth and spread.
Hydrogels are commonly used inside the body to help in tissue regeneration and drug delivery. However, once inside, they can be challenging to control for optimal use. A team of researchers in the Department of Biomedical Engineering at Texas A&M University is developing a new way to manipulate the gel - by using light.
Researchers presented data today on ARQ 092, an AKT inhibitor in Phase 1 clinical development by ArQule, Inc. at the AACR Annual Meeting held in Washington, D.C., April 6-10, showing that this novel, oral agent inhibits the AKT pathway and has a manageable safety profile in an ongoing Phase 1 clinical trial.
University of Utah Department of Medicine researchers have received $16 million from the National Institutes of Health (NIH) to set up a translational research center to study the cellular and molecular causes of blood clots, a serious threat to millions of people who have diabetes, are obese or have other metabolic disorders.
› Verified 7 days ago
Mrs. Kayla Brie Bach, MOTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 37160 Dickerson Run, Severance, CO 80550 Phone: 970-690-6696 Fax: 970-449-0525 | |
Marty Melland, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 310 Windflower Way, Severance, CO 80550 Phone: 800-259-9897 |